AlloSource Receives Gold Level Recognition for Workplace Health From the American Heart Association

Centennial, Colo. — August 9, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced it received Gold level recognition from the American Heart Association for promoting a workplace culture of health and wellbeing. The American Heart Association’s Workplace Health Achievement Index scores companies of all sizes on 55 best practices in seven categories: leadership, engagement, programs, policies and environment, partnerships, communications, and reporting outcomes. The AHA created the Index in collaboration with its CEO Roundtable members from some of America’s largest companies who are committed to applying evidence-based approaches…

AlloSource Awards Dr. Kevin Shea the Annual Dr. Steven Gitelis Inspiration Award

Centennial, Colo. — July 17, 2018 — AlloSource, one of the largest nonprofit cellular and tissue networks in the country, offering life-saving and life-enhancing solutions in orthopedic, spine, burn and wound procedures to help restore patient health and mobility, today announced that it will award Dr. Kevin Shea with its second annual Dr. Steven Gitelis Inspiration Award. The award honors a doctor or clinician that inspires AlloSource through his or her work in treating patients with allografts. Dr. Shea recently joined the Stanford University School of Medicine as a professor of orthopedic surgery and also serves as director of the…

AlloSource Partners With Tuition.io to Help Employees Pay Down Student Debt

Centennial, Colo. — May 1, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced the rollout of its student loan repayment assistance program, a new employee benefit to help workers pay off their student loans faster. The company is partnering with Tuition.io, the leading platform for employee student loan contributions, to administer the program. As part of the benefit, AlloSource employees will receive monthly contributions to help pay down the principal of their student loans. According to Willis Towers Watson, only 4% of companies in the United States offer…

AlloSource Announces Two Presentations on ProChondrix at the International Cartilage Repair Society World Congress

Centennial, Colo. — April 10, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced that clinical and scientific data on its ProChondrix® osteochondral allograft will be presented at the International Cartilage Repair Society’s 14th World Congress on Wednesday, April 11 from 13:00-14:00 in the Almaty 3 Room. Dr. Vishal Mehta will present his 24-month clinical experience with ProChondrix in the knee. Dr. Mehta performed the first ProChondrix implantation in December of 2014 and will share his clinical experience with the product. “ProChondrix has been a valuable addition to my…

AlloSource and Stryker Launch ProChondrix CR Cryopreserved Osteochondral Allograft

Centennial, Colo. – April 4, 2018 – AlloSource and Stryker today announced the launch of ProChondrix® CR, a cryopreserved osteochondral allograft. ProChondrix CR is a single-stage, natural solution for patients in need of articular cartilage repair. ProChondrix CR is designed to match biomechanical and biochemical properties of normal hyaline cartilage, restore a smooth articular cartilage surface, help relieve patient symptoms, and improve function. AlloSource launched ProChondrix in 2016 and developed a cryopreserved version to provide a longer shelf-life, while maintaining the high cellular viability of the product1. “ProChondrix CR demonstrates our commitment to innovation and our surgeon customers,” said Kerr…